BACKGROUND. While the human fetal immune system defaults to a program of tolerance, there is a concurrent need for protective immunity to meet the antigenic challenges encountered after birth. Activation of T cells in utero is associated with the fetal inflammatory response, with broad implications for the health of the fetus and of the pregnancy. However, the characteristics of the fetal effector T cells that contribute to this process are largely unknown.
METHODS.We analyzed primary human fetal lymphoid and mucosal tissues and performed phenotypic, functional, and transcriptional analysis to identify T cells with proinflammatory potential. The frequency and function of fetal-specific effector T cells was assessed in the cord blood of infants with localized and systemic inflammatory pathologies and compared with that of healthy term controls.
RESULTS.We identified a transcriptionally distinct population of CD4 + T cells characterized by expression of the transcription factor promyelocytic leukemia zinc finger (PLZF). PLZF + CD4 + T cells were specifically enriched in the fetal intestine, possessed an effector memory phenotype, and rapidly produced proinflammatory cytokines. Engagement of the C-type lectin CD161 on these cells inhibited TCR-dependent production of IFN-γ in a fetal-specific manner. IFN-γ-producing PLZF + CD4 + T cells were enriched in the cord blood of infants with gastroschisis, a natural model of chronic inflammation originating from the intestine, as well as in preterm birth, suggesting these cells contribute to fetal systemic immune activation.
CONCLUSION.Our work reveals a fetal-specific program of protective immunity whose dysregulation is associated with fetal and neonatal inflammatory pathologies. cells in the development of protective immunity and their contribution to perinatal immune dysregulation is not known.Here, we performed a detailed analysis of human CD4 + T cell phenotype and function in fetal lymphoid and mucosal tissues. We show that Vα7.2 -PLZF + TCR-αβ + CD4 + T cells (herein referred to as PLZF + CD4 + T cells) specifically accumulated in the fetal intestine and were absent from the adult. Fetal PLZF + CD4 + T cells represent a transcriptionally unique subset of CD4 + T cells that are distinct from either innate-like, semi-invariant Va7.2 + T cells or PLZF -CD4 + T cells. Consistent with a primarily T effector memo-memory originates in utero. Innate-like T cells with rapid effector functions, such as γδ T cells, mucosa-associated invariant T (MAIT) cells, and innate-like NKT cells, are also present in fetal tissues (23)(24)(25). Promyelocytic leukemia zinc finger (PLZF), a transcriptional regulator that directs the differentiation of innate-like T cells (26,27), is widely expressed in human immune cells and is commonly associated with expression of CD161, a C-type lectin receptor (28). The human fetal thymus uniquely produces a subset of CD4 + T cells, distinct from NKT cells and MAIT cells, that expresses the transcription factor PLZF (29). However, the role of fetal PLZF ...